Induction of systemic and mucosa[ immune responses in cotton rats immunized with human adenovirus type 5 recombinants expressing the full and truncated forms of bovine herpesvirus type 1 glycoprotein gD

Virology

Volumn 222, Issue 2, 1996, Pages 299-309

  Mittal, Suresh K ^a   Papp, Zsuzsanna ^c   Tikoo, Suresh K ^b   Baca Estrada, Maria E ^b   Yoo, Dongwan ^d   Benko, Maria ^e   Babiuk, Lorne A ^b,c  

^a PURDUE UNIVERSITY   (United States)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

^c UNIVERSITY OF SASKATCHEWAN   (Canada)

^d UNIVERSITY OF GUELPH   (Canada)

^e INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

HERPES VACCINE; VIRUS GLYCOPROTEIN; VIRUS VACCINE; BOVINE HERPESVIRUS TYPE 1 GLYCOPROTEINS; BOVINE HERPESVIRUS TYPE-1 GLYCOPROTEINS; RECOMBINANT VACCINE; VIRUS ANTIBODY; VIRUS PROTEIN;

ADENOVIRUS 5; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BOVINE HERPES VIRUS; CONTROLLED STUDY; IMMUNITY; IMMUNIZATION; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; VIRUS RECOMBINANT; ANIMAL; BLOOD; CELL LINE; GENE VECTOR; GENETICS; HERPES VIRUS INFECTION; HUMAN; HUMAN ADENOVIRUS; IMMUNOLOGY; INFECTIOUS BOVINE RHINOTRACHEITIS VIRUS; MUCOSAL IMMUNITY; PHYSIOLOGY; SERODIAGNOSIS; SIGMODONTINAE; VIRUS REPLICATION;

ADENOVIRUSES, HUMAN; ANIMALS; ANTIBODIES, VIRAL; CELL LINE; GENETIC VECTORS; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 1, BOVINE; HUMANS; IMMUNITY, MUCOSAL; IMMUNIZATION; PRECIPITIN TESTS; SIGMODONTINAE; VACCINES, SYNTHETIC; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 0030586402     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.0427     Document Type: Article

References (56)

1. Alkhatib, G., and Briedis, D. J. (1988). High-level eukaryotic in vivo expression of biologically active measles virus hemagglutinin by using an adenovirus type 5 helper-free vector system. J. Virol. 62, 2718-2727.
2. Andrew, M. E., Boyle, D. B., Whitfeld, P. L., Lockett, L. J., Anthony, I. D., Bellamy, A. R., and Both, G. W. (1990). The immunogenicity of VP7, a rotavirus antigen resident in the endoplasmic reticulum, is enhanced by cell surface expression. J. Virol. 64, 4776-4783.
3. Babiuk, L. A., L'italien, J., van Drunen Littel-van Den Hurk, S., Zamb, T., Lawman, M. J. P., Hughes, G., and Gifford, G. A. (1987). Protection of cattle from bovine herpesvirus type 1 (BHV-1) infection by immunization with individual viral glycoproteins. Virology 159, 57-66.
4. Baca-Estrada, M. E., Snider, M., Tikoo, S. K., Harland, R., Babiuk, L. A., and van Drunen Littel-van den Hurk, S. (1996). Immunogenicity of bovine herpesvirus 1 glycoprotein D in mice: Effect of antigen form on the induction of cellular and humoral immune responses. Viral Immunol. 9, 11-22.
5. Berkner, K. L. (1992). Expression of heterologous sequences in adenoviral vectors. Curr. Top. Microbiol. Immunol. 158, 39-66.
6. Berkner, K. L., and Sharp, P. A. (1984). Expression of dihydrofolate reductase and of the adjacent E1b region in an Ad5-dihydrofolate reductase recombinant virus. Nucleic Acids Res. 12, 1925-1941.
7. Bett, A. J., Prevec, L., and Graham, F. L. (1993). Packaging capacity and stability of human adenovirus type 5 vectors. J. Virol. 67, 5911-5921.
8. Braciak, T. A., Mittal, S. K., Graham, F. L., Richards, C. D., and Gauldie, J. (1993). Construction of recombinant human type 5 adenoviruses expressing rodent IL-6 genes: An approach to investigate in vivo cytokine function. J. Immunol. 151, 5145-5153.
9. Breker-Nassen, M. M., Yoo, D., Mittal, S. K., Sorden, S. D., Haines, D. M., and Babiuk, L. A. (1995). Recombinant adenovirus type 5 expressing bovine parainfluenza virus type 3 glycoproteins protect Sigmodon hispidus cotton rats from bovine parainfluenza virus type 3 infection. J. Virol. 69, 4308-4315.
10. Chanda, P. K., Natuk, R. J., Mason, B. B., Bhat, B. M., Greenberg, L., Dheer, S. K., Molnar-Kimber, K. L., Mizutani, S., Lubeck, M. D., Davis, A. R., and Hung, P. P. (1990). High level expression of the envelope glycoproteins of the human immunodeficiency virus type I in presence of rev gene using helper-independent adenovirus type 7 recombinants. Virology 175, 535-547.
11. Engelhardt, J. F., Ye, X., Doranz, B., and Wilson, J. M. (1994). Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc. Natl. Acad. Sci. USA 91, 6196-6200.
12. Fehler, F., Herrmann, J. M., Saalmuller, A., Mettenleiter, T. C., and Keil, G. M. (1992). Glycoprotein IV of bovine herpesvirus expressing cell line complements and rescues a conditionally lethal viral mutant. J. Virol. 66, 831-839.
13. Fooks, A. R., Schadeck, E., Liebert, U. G., Dowsett, A. B., Rima, B. K., Steward, M., Stephenson, J. R., and Wilkinson, W. G. (1995). High-level expression of the measles virus nucleocapsid protein by using a replication-deficient adenovirus vector: Induction of an MHC-1-restricted CTL response and protection in a murine model. Virology 210, 456-465.
14. Gluzman, Y., Reichl, H., and Solnick, D. (1982). Helper-free adenovirus type 5 vectors. In "Eucaryotic Viral Vectors" (Y. Gluzman, Ed.), pp. 187-192. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
15. Graham, F. L. (1990). Adenoviruses as expression vectors and recombinant vaccines. Trends Biotechnol. 8, 85-87.
16. Graham, F. L., and van der Eb, A. J. (1973). A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52, 456-467.
17. Graham, F. L., and Prevec, L. (1991). Manipulation of adenovirus vectors. In "Methods in Molecular Biology, Vol. 7, Gene Transfer and Expression Protocols" (E. J. Murray, Ed.), pp. 109-128. The Humana Press, Clifton, NJ.
18. Graham, F. L., and Prevec, L. (1992). Adenovirus expression vectors and recombinant vaccines. In "Vaccines: New Approaches to Immunological Problems" (R. W. Ellis, Ed.), pp. 363-390. Butterworth-Heinemann, Boston.
19. Graham, F. L., Smiley, J. W., Russell, W. C., and Nairn, R. (1977). Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36, 59-72.
20. Haj-Ahmad, Y., and Graham, F. L. (1986). Development of a helper independent human adenovirus vector and its use in the transfer of the herpes simplex virus thymidine kinase gene. J. Virol. 57, 267-274.
21. Hughes, G., Babiuk, L. A., and van Drunen Littel-van den Hurk, S. (1988). Functional and topographical analyses of epitopes on bovine herpesvirus-1 glycoprotein IV. Arch. Virol. 103, 47-60.
22. Johnson, D. C., Ghosh-Choudhury, G., Smiley, J. R., Fallis, L., and Graham, F. L. (1988). Abundant expression of herpes simplex virus glycoprotein gB using an adenovirus vector. Virology 164, 1-14.
23. Khadr, A., Tikoo, S. K., Babiuk, L. A., and van Drunen Littel-van den Hurk, S. (1996). Sequence and expression of a bovine herpesvirus-1 gene homolous to the glycoprotein K-encoding gene of herpes simplex virus-1. Gene 168, 189-193.
24. Khattar, S. K., van Drunen Littel-van den Hurk, S., Babiuk, S. K., and Tikoo, S. K. (1995). Identification and transcriptional analysis of a 3′-coterminal gene cluster containing UL1, UL2, UL3 and UL3.5 open reading frames of bovine herpesvirus-1. Virology 213, 28-37.
25. Khattar, S. K., van Drunen Littel-van den Hurk, S., Attah-Poku, S., Babiuk, L. A., and Tikoo, S. K. (1996). Identification and characterization of bovine herpesvirus 1 glycoprotein gL which is required for proper antigenicity, processing and transport of BHV-1 glycoprotein gH. Virology 219, 66-76.
26. Kowalski, J., Gilbert, S. A., van Drunen Littel-van den Hurk, S., Van Den Hurk, J., Babiuk, L. A., and Zamb, T. (1993). Heat-shock promoter-driven synthesis of secreted bovine herpesvirus glycoproteins in transfected cells. Vaccine 11, 1100-1107.
27. Lamarche, N., Massie, B., Rcher, M., Paradis, H., and Langelier, Y. (1990). High level expression in 293 cells of the herpes simplex virus type 2 ribonucleotide reductase subunit 2 using an adenovirus vector. J. Gen. Virol. 71, 1785-1792.
28. Langford, C. J., Edwards, S. J., Smith, G. L., Mitchell, G. F., Moss, B., Kemp, D. J., and Anders, F. F. (1986). Anchoring a secreted Plasmodium antigen on the surface of recombinant vaccinia virus-infected cells increases its immunogenicity. Mol. Cell. Biol. 6, 3191-3199.
29. Lubeck, M. D., Davis, A. R., Chengalvala, M., Natuk, R. J., Morin, J. E., Molnar-Kimber, K., Mason, B. B., Bhat, B. M., Mizutani, S., Hung, P. P., and Purcell, R. H. (1989). Immunogenicity and efficacy testing in chimpanzees of an oral hepatitis B vaccine based on live recombinant adenovirus. Proc. Natl. Acad. Sci. USA 86, 6763-6767.
30. Men, R. H., Bray, M., and Lai, C. J. (1991). Carboxy-terminally truncated dengue virus envelope glycoproteins expressed on the cell surface and secreted extracellularly exhibit increased immunogenicity in mice. J. Virol. 65, 1400-1407.
31. Mittel, S. K., McDermott, M. R., Johnson, D. C., Prevec, L., and Graham, F. L. (1993). Monitoring foreign gene expression by a human adenovirus-based vector using the firefly luciferase gene as a reporter. Virus Res. 28, 67-90.
32. Mittal, S. K., McDermott, M. R., Johnson, D. C., Prevec, L., Zamb, T., Babiuk, L. A., and Graham, F. L. (1994). Adenovirus based expression vectors for recombinant vaccines. In "Recombinant and Synthetic Vaccines" (G. P. Talwar et al., Eds.), pp. 362-366. Springer-Verlag, New York.
33. Mittal, S. K., Bett, A. J., Prevec, L., and Graham, F. L. (1995a). Foreign gene expression by human adenovirus type 5 based vectors studied using firefly luciferase and bacterial beta-galactosidase genes as reporters. Virology 210, 226-230.
34. Mittal, S. K., Middleton, D. M., Tikoo, S. K., and Babiuk, L. A. (1995b). Pathogenesis and immunogenicity of bovine adenovirus type 3 in cotton rats (Sigmodon hispidus). Virology 213, 131-139.
35. Pacini, D. L., Dubovi, E. J., and Clyde, W. A., Jr. (1984). A new animal model for human respiratory tract disease due to adenovirus. J. Infect. Dis. 150, 92-97.
36. Prevec, L., Schneider, M., Rosenthal, K. L., Belbeck, L. W., Derbyshire, J. B., and Graham, F. L. (1989). Use of human adenovirus-based vectors for antigen expression in animals. J. Gen. Virol. 70, 429-434.
37. Prevec, L., Campbell, J. B., Christie, B. S., Belbeck, L., and Graham, F. L. (1990). A recombinant human adenovirus vaccine against rabies. J. Infect. Dis. 161, 27-30.
38. Prince, G. A., Porter, D. D., Jenson, A. B., Horswood, R. L., Chanock, R. M., and Ginsberg, H. S. (1993). Pathogenesis of adenovirus type 5 pneumonia in cotton rats (Sigmodon hispidus). J. Virol. 67, 101-111.
39. Ragot, T., Finerty, S., Watkins, P. E., Perricaudet, M., and Morgan, A. J. (1993a). Replication-defective recombinant adenovirus expressing the Epstein-Barr virus (EBV) envelope glycoprotein gp340/220 induces protective immunity against EBV-induced lymphomas in the cottontop tamaris. J. Gen. Virol. 74, 501-507.
40. Ragot, T., Vincent, N., Chafey, P., Vigne, E., Gilgenkrantz, H., Couton, D., Cartaud, J., Briand, P., Kaplan, J.-C., Perricaudet, M., and Kahn, A. (1993b). Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice. Nature 361, 647-650.
41. Rosenfeld, M. A., Yoshimura, K., Trapnell, B. C., Yoneyama, K., Rosenthal, E. R., Dalemans, W., Fukayama, M., Bargon, J., Stier, L. E., Stratford-Perricaudet, L., Perricaudet, M., Guggino, W. B., Pavirani, A., Lecocq, J.-P., and Crystal, R. G. (1992). In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 68, 141-155.
42. Rouse, B. T., and Babiuk, L. A. (1974). Host responses to infectious bovine rhinotracheitis. III. Isolation and immunological activities of bovine lymphocytes. J. Immunol. 113, 1391-1398.
43. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989). "Molecular Cloning: A Laboratory Manual," 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
44. Tikoo, S. K., Fitzpatrick, D., Babiuk, L. A., and Timb, Z. (1990). Molecular cloning, sequencing, and expression of functional bovine herpesvirus 1 glycoprotein gIV in transfected bovine cells. J. Virol. 64, 5132-5142.
45. Tikoo, S. K., Parker, M. D., van den Hurk, J. V., Kowalski, J., Zamb, T. J., and Babiuk, L. A. (1993a). Role of N-linked glycans in antigenicity, processing, and cell surface expression of bovine herpesvirus 1 glycoprotein gIV. J. Virol. 67, 726-733.
46. Tikoo, S. K., Zamb, T. J., and Babiuk, L. A. (1993b). Analysis of bovine herpesvirus 1 glycoprotein gIV truncations and deletions expressed by recombinant vaccinia viruses. J. Virol. 67, 2103-2109.
47. Tikoo, S. K., Campos, M., and Babiuk, L. A. (1995). Bovine herpesvirus 1 (BHV-1): Biology, pathogenesis, and control. Adv. Virus Res. 45, 191-223.
48. Torres, J. M., Alonso, C., Ortega, A., Mittal, S., Graham, F. L., and Enjuanes, L. (1996). Tropism of human adenovirus 5 based vectors in swine and their ability to protect against transmissible gastroenteritis coronavirus. J. Virol. 70, 3770-3780.
49. van Drunen Littel-van den Hurk, S., and Babiuk, L. A. (1986). Synthesis and processing of bovine herpesvirus 1 glycoproteins. J. Virol. 59, 401-410.
50. van Drunen Littel-van den Hurk, S., van den Hurk, J. V., Gilchrist, J. E., Misra, V., and Babiuk, L. A. (1984). Interactions of monoclonal antibodies and bovine herpesvirus type-1 (BHV-1) glycoproteins. Virology 135, 466-479.
51. van Drunen Littel-van den Hurk, S., Gifford, G. A., and Babiuk, L. A. (1990). Epitope specificity of the protective immune response induced by individual bovine herpesvirus-1 glycoproteins. Vaccine 8, 358-368.
52. van Drunen Littel-van den Hurk, S., Parker, M. D., Massie, B., van den Hurk, J., Harland, R., Babiuk, L. A., and Zamb, T. J. (1993). Protection of cattle from BHV-1 infection by immunization with recombinant glycoprotein gIV. Vaccine 11, 25-35.
53. van Drunen Littel-van den Hurk, S., van Donkersgoed, J., Kowalski, J., van den Hurk, J., Harland, R., Babiuk, L. A., and Zamb, T. J. (1994). A subunit gIV vaccine produced by transfected mammalian cells in culture, induces mucosal immunity against bovine herpesvirus-1 in cattle. Vaccine 12, 1295-1302.
54. Vlcek, C., Benes, V., Lu, Z., Kutish, G. F., Paces, V., Rock, D., Letchworth, G. J., and Schwyzer, M. (1995). Nucleotide sequence analysis of a 30-kb region of the bovine herpesvirus 1 genome which exhibits a colinear gene arrangement with the UL21 to UL4 genes of herpes simplex virus. Virology 210, 100-108.
55. Yang, Y., Xiang, Z., Ertl, H. C., and Wilson, J. M. (1995). Upregulation of class I major histocompatibility complex antigens by interferon gamma is necessary for T cell-mediated elimination of recombinant adenovirus-infected hepatocytes in vivo. Proc. Natl. Acad. Sci. USA 92, 7257-7261.
56. Yates, W. D. G. (1982). A review of infectious bovine rhinotracheitis, shipping fever pneumonia and viral-bacterial synergism in respiratory disease of cattle. Can. J. Comp. Med. 46, 225-263.